These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2492166

  • 21. The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks.
    Grunhaus L, Tiongco D, Haskett RF, Greden JF.
    Biol Psychiatry; 1987 Apr; 22(4):517-21. PubMed ID: 3567265
    [No Abstract] [Full Text] [Related]

  • 22. Platelet serotonin uptake in panic disorder.
    Norman TR, Judd FK, Gregory M, James RH, Kimber NM, McIntyre IM, Burrows GD.
    J Affect Disord; 1986 Apr; 11(1):69-72. PubMed ID: 2944930
    [Abstract] [Full Text] [Related]

  • 23. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD, Papp LA, Martinez J, Pine D, Rosenblum LA, Cooper T, Liebowitz MR, Gorman JM.
    Am J Psychiatry; 1995 Apr; 152(4):619-22. PubMed ID: 7694915
    [Abstract] [Full Text] [Related]

  • 24. Prolactin and sodium lactate-induced panic.
    Hollander E, Liebowitz MR, Cohen B, Gorman JM, Fyer AJ, Papp LA, Klein DF.
    Psychiatry Res; 1989 May; 28(2):181-91. PubMed ID: 2748770
    [Abstract] [Full Text] [Related]

  • 25. Growth hormone-releasing factor stimulation test in depression.
    Krishnan KR, Manepalli AN, Ritchie JC, Rayasam K, Melville ML, Daughtry G, Thorner MO, Rivier JE, Vale WW, Nemeroff CB.
    Am J Psychiatry; 1988 Jan; 145(1):90-2. PubMed ID: 2827532
    [Abstract] [Full Text] [Related]

  • 26. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
    Hulse JA, Rosenthal SM, Cuttler L, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
    [Abstract] [Full Text] [Related]

  • 27. Basal adrenocortical activity and DST in electrodermally differentiated subgroups of panic patients.
    Kopp MS, Arató M, Magyar I, Buza K.
    Int J Psychophysiol; 1989 Mar; 7(1):77-83. PubMed ID: 2925467
    [Abstract] [Full Text] [Related]

  • 28. [The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases].
    Cottraux J, Claustrat B.
    Encephale; 1984 Mar; 10(6):267-72. PubMed ID: 6529933
    [Abstract] [Full Text] [Related]

  • 29. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
    Rosenthal SM, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
    [Abstract] [Full Text] [Related]

  • 30. A 3H-flunitrazepam binding inhibitor is present in psychiatric patients' sera.
    Marazziti D, Pietrini P, Martini C, Giannaccini G, Perugi G, Placidi GF, Cassano GB, Lucacchini A.
    Neuropsychobiology; 1987 Jun; 18(2):74-6. PubMed ID: 2836759
    [Abstract] [Full Text] [Related]

  • 31. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M, Frohman LA.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [Abstract] [Full Text] [Related]

  • 32. Growth hormone response to growth hormone-releasing hormone and clonidine in young monkeys: correlation with behavioral characteristics.
    Coleman K, Dahl RE, Ryan ND, Cameron JL.
    J Child Adolesc Psychopharmacol; 2003 Jul; 13(3):227-41. PubMed ID: 14642012
    [Abstract] [Full Text] [Related]

  • 33. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH.
    Bamberger CM, Mönig H, Mill G, Gödde E, Schulte HM.
    Exp Clin Endocrinol Diabetes; 1995 Jul; 103(3):205-8. PubMed ID: 7584524
    [Abstract] [Full Text] [Related]

  • 34. Thyroid hormone levels in panic disorder.
    Yeragani VK, Rainey JM, Pohl R, Ortiz A, Weinberg P, Gershon S.
    Can J Psychiatry; 1987 Aug; 32(6):467-9. PubMed ID: 3690476
    [Abstract] [Full Text] [Related]

  • 35. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
    Chapman IM, Hartman ML, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
    [Abstract] [Full Text] [Related]

  • 36. Platelet [3H]imipramine binding in patients with panic disorder.
    Uhde TW, Berrettini WH, Roy-Byrne PP, Boulenger JP, Post RM.
    Biol Psychiatry; 1987 Jan; 22(1):52-8. PubMed ID: 3790640
    [Abstract] [Full Text] [Related]

  • 37. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [Abstract] [Full Text] [Related]

  • 38. CSF prostaglandin-E in agoraphobia with panic attacks.
    Anton RF, Ballenger JC, Lydiard RB, Laraia MT, Howell EF, Gold PW.
    Biol Psychiatry; 1989 Jul; 26(3):257-64. PubMed ID: 2545288
    [Abstract] [Full Text] [Related]

  • 39. Intravenous refeeding blocks growth hormone (GH)-provoked rises in serum free fatty acids and blunting of somatotroph response to GH-releasing hormone in normal men.
    Rosenbaum M, Fong YM, Hesse DG, Tracey KJ, Hintz RL, Lowry SF, Gertner JM.
    J Clin Endocrinol Metab; 1989 Aug; 69(2):310-6. PubMed ID: 2502553
    [Abstract] [Full Text] [Related]

  • 40. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, Curtis GC.
    Biol Psychiatry; 1992 Jul 01; 32(1):18-25. PubMed ID: 1391293
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.